# Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

Study · id `cardio:ct-nct01151137` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01151137](<https://clinicaltrials.gov/study/NCT01151137>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01151137

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 3236 participants.

## Technical summary

Registry record NCT01151137. Randomized; triple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2012-10-26.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 3236 participants (enrolled count; ClinicalTrials.gov record NCT01151137, source copy `cardio:ctgov-nct01151137-2012-10-26`, retrieved 2026-10-26)
- Start date: 2010-07 (registry gives no type) (ClinicalTrials.gov record NCT01151137, source copy `cardio:ctgov-nct01151137-2012-10-26`, retrieved 2026-10-26)
- Primary completion: 2011-09 (actual) (ClinicalTrials.gov record NCT01151137, source copy `cardio:ctgov-nct01151137-2012-10-26`, retrieved 2026-10-26)
- Completion: 2011-09 (actual) (ClinicalTrials.gov record NCT01151137, source copy `cardio:ctgov-nct01151137-2012-10-26`, retrieved 2026-10-26)
- Results first posted: 2012-10-26 (ClinicalTrials.gov record NCT01151137, source copy `cardio:ctgov-nct01151137-2012-10-26`, retrieved 2026-10-26)
- Countries: United States; Argentina; Australia; Austria; Belgium; Brazil; Bulgaria; Canada; Chile; Czechia; Denmark; Finland; France; Germany; Greece; Hong Kong SAR China; Hungary; Israel; Italy; Malaysia; Mexico; Netherlands; New Zealand; Norway; Poland; Romania; Russia; Singapore; Slovakia; South Africa; South Korea; Spain; Sweden; Switzerland; Taiwan; Ukraine; United Kingdom (ClinicalTrials.gov record NCT01151137, source copy `cardio:ctgov-nct01151137-2012-10-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01151137-2012-10-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
- Acronym: PALLAS
- Condition: Atrial Fibrillation
- Intervention (Drug): Dronedarone
- Intervention (Drug): Placebo (for Dronedarone)
- Lead sponsor: Sanofi
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Sanofi (`cardio:org-sanofi`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Dronedarone in high-risk permanent atrial fibrillation (`cardio:pubmed-22082198`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Interaction between digoxin and dronedarone in the PALLAS trial (`cardio:pubmed-25378467`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 97a97ed116a7c45aea7eeb878932c650526c5abe2d8e1849ef261ea643a0a858
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
